HYTN Receives GMP Certificates for The United States, Bermuda and Israel

VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a leader in pharmaceutical-grade cannabis manufacturing, is pleased to announce that it has received digital Good Manufacturing Practices (GMP) certificates (the “Certificates”) from Health Canada, confirming the GMP compliance of its Kelowna-based manufacturing facility. Issued under HYTN’s Drug Establishment Licence (“DEL”), these Certificates specifically acknowledge the Company’s GMP status for the United States, Bermuda, and Israel.